Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123910242 | 12391024 | 2 | F | 2011 | 20160719 | 20160520 | 20160726 | EXP | US-DSJP-DSU-2011-08781-1 | DAIICHI | 0.00 | Y | 0.00000 | 20160726 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123910242 | 12391024 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | Y | 21286 | 40 | MG | TABLET | QD | |||||
| 123910242 | 12391024 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, UNK | Y | 21286 | 20 | MG | TABLET | |||||||
| 123910242 | 12391024 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/12.5MG,QD | Y | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 123910242 | 12391024 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | UNK | Y | 0 | FILM-COATED TABLET | |||||||||
| 123910242 | 12391024 | 5 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 80 MG, QD | 0 | 80 | MG | TABLET | QD | ||||||
| 123910242 | 12391024 | 6 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 123910242 | 12391024 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 5 MG, QD | 0 | 5 | MG | TABLET | QD | |||||||
| 123910242 | 12391024 | 8 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 123910242 | 12391024 | 9 | C | LASIX | FUROSEMIDE | 1 | UNK, BID | 0 | BID | ||||||||||
| 123910242 | 12391024 | 10 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 12.5 MG, QD | 0 | 12.5 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123910242 | 12391024 | 1 | Hypertension |
| 123910242 | 12391024 | 3 | Hypertension |
| 123910242 | 12391024 | 5 | Hypercholesterolaemia |
| 123910242 | 12391024 | 6 | Product used for unknown indication |
| 123910242 | 12391024 | 8 | Oedema peripheral |
| 123910242 | 12391024 | 10 | Diuretic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123910242 | 12391024 | OT |
| 123910242 | 12391024 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123910242 | 12391024 | Acute kidney injury | |
| 123910242 | 12391024 | Coeliac disease | |
| 123910242 | 12391024 | Drug ineffective | |
| 123910242 | 12391024 | Drug prescribing error | |
| 123910242 | 12391024 | Enteritis | |
| 123910242 | 12391024 | Hiatus hernia | |
| 123910242 | 12391024 | Intestinal ulcer | |
| 123910242 | 12391024 | Malabsorption | |
| 123910242 | 12391024 | Oedema peripheral | |
| 123910242 | 12391024 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123910242 | 12391024 | 1 | 201107 | 201305 | 0 | |
| 123910242 | 12391024 | 3 | 2009 | 2011 | 0 | |
| 123910242 | 12391024 | 4 | 20110610 | 0 |